LAS VEGAS—Innovations around generative AI are rapidly coming into the healthcare market.
But fewer than 1 in 10 healthcare organizations have concrete plans in place for execution, according to a Bain & Company survey.
Leading health systems are joining together with health plans, research organizations, tech companies and nonprofit associations to help bridge this gap by exploring uses, pitfalls and best practices for generative AI in healthcare and research, and accelerate execution and real-world evidence.
UC Davis Health along with the rest of the University of California health systems and more than 30 founding partners to launch VALID AI, which stands for Vision, Alignment, Learning, Implementation, and Dissemination of Validated Generative AI in Healthcare.
“By embracing open innovation and radical collaboration, healthcare organizations of all sizes can lead the charge in creating value from Gen AI in a responsible manner,” said Ashish Atreja, CIO and chief digital health officer at UC Davis Health, in a statement. “We now have an opportunity to co-create the science of Gen AI with our diverse partners in a way that could fundamentally change how care and research will be delivered in the future.” By bringing together diverse perspectives, expertise, and insights, VALID AI will push the boundaries of implementing AI technology and ensure the responsible and ethical development of Gen AI, ultimately shaping a more equitable future for all.
According to the founding partners, the VALID AI program revolves around a collective of five core values. The aim is to create a cohesive strategy and shared vision to guide generative AI research in healthcare, aligning relevant parties, facilitating learning, promoting equitable access to generative AI resources and accelerating implementation across member organizations.
The collaboration also aims to develop common standards and apply those standards with best-suited organizational frameworks and safe and equitable governance practices.
The organizations also will aggregate research on use cases, implementation science, policy work and industry standards from the U.S. and globally.
The organizations also will work together to establish the "collaborative AI sandbox"to support member organizations with integration, validation and implementation of generative AI use cases.
"Gen AI holds tremendous promise for health care but requires guardrails to ensure safety and efficacy,” said Dennis Chornenky, chief AI advisor at UC Davis Health and CEO of Domelabs AI, in a statement. “VALID AI will accelerate adoption through coordinated validation of use-cases and alignment around best practices for AI governance and AI-enabled innovation.”
The organizations also plan to share the knowledge and science generated through collective efforts on a global scale through co-publishing white papers, journal articles and op-eds to advance innovation.
Other health system and health plan founding partners include Atlantic Health, Cedars-Sinai, CommonSpirit Health, Houston Methodist, MedStar Health, NewYork-Presbyterian, Ochsner Health and Yale New Haven Health System, among others.
The American Cancer Society also is joining the collaboration along with BrainX AI, Center for Health Technology & Innovation – American Heart Association, Coalition for Health AI, Node.Health and the Peterson Health Technology Institute (PHTI).